RECRUITING

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Description

This is a feasibility study that will collect data to assess the potential effect of a nutritional intervention designed to improve liver metabolism. This prospective single-site trial will enroll adult patients undergoing liver-directed therapies for hepatocellular carcinoma. Eligible individuals who are randomized to the intervention group will be enrolled in a six-month nutritional change program consisting of time-restricted eating in which calorie consumption is limited to 8-10 hours during the day, plus targeted healthy changes in what they eat. The intervention includes dietary counseling visits with a study registered dietitian and motivational phone calls with a study Certified Health and Wellness Coach to help subjects adhere to the intervention. Individuals in the control group will be enrolled in a six-month period of observation only. The main questions it aims to answer are: Is a prolonged nightly fast coupled with a healthy diet safe and feasible for patients with liver cancer? Does the intervention improve liver metabolism?

Conditions

Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight
Talk to us

Related Conditions:

Liver Cancer, AdultMASH - Metabolic Dysfunction-Associated SteatohepatitisObesity and Overweight

Study Overview

On this page

Study Details

Study overview

This is a feasibility study that will collect data to assess the potential effect of a nutritional intervention designed to improve liver metabolism. This prospective single-site trial will enroll adult patients undergoing liver-directed therapies for hepatocellular carcinoma. Eligible individuals who are randomized to the intervention group will be enrolled in a six-month nutritional change program consisting of time-restricted eating in which calorie consumption is limited to 8-10 hours during the day, plus targeted healthy changes in what they eat. The intervention includes dietary counseling visits with a study registered dietitian and motivational phone calls with a study Certified Health and Wellness Coach to help subjects adhere to the intervention. Individuals in the control group will be enrolled in a six-month period of observation only. The main questions it aims to answer are: Is a prolonged nightly fast coupled with a healthy diet safe and feasible for patients with liver cancer? Does the intervention improve liver metabolism?

Feasibility Study of Time Restricted Eating and a Healthy Diet in Patients Receiving Liver-Directed Therapy for Hepatocellular Carcinoma

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

Condition
Liver Cancer, Adult
Intervention / Treatment

-

Contacts and Locations

La Jolla

University of California San Diego, La Jolla, California, United States, 92093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Overweight or obese (BMI 27-45 kg/m2)
  • 2. BCLC early to intermediate stage HCC
  • 3. Referred for liver-directed therapy (PTA, TACE, TARE within 3 months)
  • 4. English or Spanish speaking over the age of 18.
  • 5. ECOG Performance Status ≤ 2.
  • 6. Usual nightly fasting \<12 hours
  • 7. Willing to comply with all study procedures
  • 8. Child-Pugh A liver function.
  • 1. Advanced HCC, progression, and/or associated comorbidities, metastatic disease, tumor in vein, or ascites
  • 2. Advanced Cirrhosis (hypoalbuminemia/Child-Pugh B+C). Poorly controlled or refractory (grade 3-4) hepatic encephalopathy
  • 3. Type 1 diabetes or self-reported hypoglycemia or hypoglycemic events by CGM
  • 4. Participation in another conflicting study that requires modification of diet or food timing.
  • 5. Uncontrollable eating pattern (e.g., wasting, Night Eating Syndrome, disordered eating habits, food insecurity)
  • 6. Medications that markedly impact metabolic study biomarkers.
  • 7. Other cancer in last 10 years (other than nonmelanoma skin cancer or carcinoma of the cervix in situ)
  • 8. Serious medical conditions such as chronic kidney disease, congestive heart failure, or any condition that would interfere with participation in the trial.
  • 9. Unresolved toxicity ≥ CTCAE Grade 2 from previous anti-cancer therapy
  • 10. Active alcohol abuse or less than 6 months of sobriety
  • 11. Participation in a trial of an investigational agent within the prior 30 days
  • 12. Pregnancy or lactating

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Nick Webster, PhD, PRINCIPAL_INVESTIGATOR, Universoty of California San Diego

Study Record Dates

2027-12